These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35306736)
1. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy. Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736 [TBL] [Abstract][Full Text] [Related]
2. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells. Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608 [TBL] [Abstract][Full Text] [Related]
3. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer. Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501 [TBL] [Abstract][Full Text] [Related]
4. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma. Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156 [TBL] [Abstract][Full Text] [Related]
5. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency. Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435 [TBL] [Abstract][Full Text] [Related]
6. A novel strategy to fabricate doxorubicin/bovine serum albumin/porous silicon nanocomposites with pH-triggered drug delivery for cancer therapy in vitro. Xia B; Zhang W; Shi J; Xiao SJ J Mater Chem B; 2014 Aug; 2(32):5280-5286. PubMed ID: 32261669 [TBL] [Abstract][Full Text] [Related]
7. Iron-silicate-coated porous silicon nanoparticles for in situ ROS self-generation. Um H; Kang RH; Kim D Colloids Surf B Biointerfaces; 2023 May; 225():113273. PubMed ID: 36965332 [TBL] [Abstract][Full Text] [Related]
8. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery. Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243 [TBL] [Abstract][Full Text] [Related]
9. Free-Standing Hierarchically Porous Silica Nanoparticle Superstructures: Bridging the Nano- to Microscale for Tailorable Delivery of Small and Large Therapeutics. Palvai S; Kpeglo D; Newham G; Peyman SA; Evans SD; Ong ZY ACS Appl Mater Interfaces; 2024 Feb; 16(5):5568-5581. PubMed ID: 38270578 [TBL] [Abstract][Full Text] [Related]
10. Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging. Park Y; Yoo J; Kang MH; Kwon W; Joo J J Mater Chem B; 2019 Nov; 7(41):6271-6292. PubMed ID: 31393507 [TBL] [Abstract][Full Text] [Related]
11. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Yong T; Zhang X; Bie N; Zhang H; Zhang X; Li F; Hakeem A; Hu J; Gan L; Santos HA; Yang X Nat Commun; 2019 Aug; 10(1):3838. PubMed ID: 31444335 [TBL] [Abstract][Full Text] [Related]
12. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin. Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714 [TBL] [Abstract][Full Text] [Related]
13. Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy. Wong RCH; Ng DKP; Fong WP; Lo PC Chemistry; 2017 Nov; 23(65):16505-16515. PubMed ID: 28771861 [TBL] [Abstract][Full Text] [Related]
14. Gold-capped mesoporous silica nanoparticles as an excellent enzyme-responsive nanocarrier for controlled doxorubicin delivery. Eskandari P; Bigdeli B; Porgham Daryasari M; Baharifar H; Bazri B; Shourian M; Amani A; Sadighi A; Goliaei B; Khoobi M; Saboury AA J Drug Target; 2019 Dec; 27(10):1084-1093. PubMed ID: 30900473 [TBL] [Abstract][Full Text] [Related]
15. Domino-Like Intercellular Delivery of Undecylenic Acid-Conjugated Porous Silicon Nanoparticles for Deep Tumor Penetration. Yong T; Hu J; Zhang X; Li F; Yang H; Gan L; Yang X ACS Appl Mater Interfaces; 2016 Oct; 8(41):27611-27621. PubMed ID: 27653799 [TBL] [Abstract][Full Text] [Related]
16. Stealth Biocompatible Si-Based Nanoparticles for Biomedical Applications. Liu W; Chaix A; Gary-Bobo M; Angeletti B; Masion A; Da Silva A; Daurat M; Lichon L; Garcia M; Morère A; El Cheikh K; Durand JO; Cunin F; Auffan M Nanomaterials (Basel); 2017 Sep; 7(10):. PubMed ID: 28946628 [TBL] [Abstract][Full Text] [Related]
17. Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake. Wang CF; Mäkilä EM; Kaasalainen MH; Liu D; Sarparanta MP; Airaksinen AJ; Salonen JJ; Hirvonen JT; Santos HA Biomaterials; 2014 Jan; 35(4):1257-66. PubMed ID: 24211082 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional Chitosan/Porous Silicon@Au Nanocomposite Hydrogels for Long-Term and Repeatedly Localized Combinatorial Therapy of Cancer via a Single Injection. Xia B; Zhang W; Tong H; Li J; Chen Z; Shi J ACS Biomater Sci Eng; 2019 Apr; 5(4):1857-1867. PubMed ID: 33405559 [TBL] [Abstract][Full Text] [Related]
20. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy. Rajkumar S; Prabaharan M Colloids Surf B Biointerfaces; 2018 Oct; 170():529-537. PubMed ID: 29966906 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]